Molecular alterations (MA) with potential therapeutic implications in KRAS wild-type (WT) pancreatic cancer patients

被引：0
|
作者：
Acosta Eyzaguirre, D. A. [1 ]
Verdaguer, H. [1 ]
Buxo, E. [1 ]
Garcia-Alvarez, A. [1 ]
Sardo, E. [2 ]
Hernando, J. [1 ]
Diez Garcia, M. [1 ]
Guardiola, M. [3 ,4 ]
Ros Montana, F. J. [1 ]
Baraibar Argota, I. [1 ]
Saoudi, N. [1 ]
Marmolejo Castaneda, D. H. [1 ]
Aguilar, S. [5 ]
Sierra, A. [5 ]
Vivancos, A. [6 ]
Dienstmann, R. [3 ,4 ]
Macarulla Mercade, T. [1 ]
机构：
[1] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain
[2] Sanat Allende, Med Oncol, Cordoba, Argentina
[3] Vall dHebron Univ Hosp, Oncol Data Sci, Barcelona, Spain
[4] Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[5] VHIO, Prescreening Program, Barcelona, Spain
[6] Vall dHebron Inst Oncol VHIO, Canc Genom, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.2032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1549P
引用
收藏
页码：S948 / S948
页数：1
相关论文
共 50 条
  • [1] Enrichment of alterations in targetable molecular pathways in KRAS wild-type (WT) pancreatic cancer (PC).
    Philip, Philip Agop
    Xiu, Joanne
    Hall, Michael J.
    Hendifar, Andrew Eugene
    Lou, Emil
    Hwang, Jimmy J.
    Gong, Jun
    Khushman, Moh'd M.
    Sohal, Davendra
    Lockhart, A. Craig
    Weinberg, Benjamin Adam
    Marshall, John
    Grothey, Axel
    Shields, Anthony Frank
    Korn, Wolfgang Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] KRAS Wild-Type Pancreatic Cancer: Decoding Genomics, Unlocking Therapeutic Potential
    Kato, Hiroyuki
    Ellis, Haley
    Bardeesy, Nabeel
    CLINICAL CANCER RESEARCH, 2023, 29 (22) : 4527 - 4529
  • [3] Identifying Actionable Alterations in KRAS Wild-Type Pancreatic Cancer
    Elhariri, Ahmed
    Patel, Jaydeepbhai
    Mahadevia, Himil
    Albelal, Douaa
    Ahmed, Ahmed K.
    Jones, Jeremy C.
    Borad, Mitesh J.
    Babiker, Hani
    TARGETED ONCOLOGY, 2024, 19 (05) : 679 - 689
  • [4] Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer
    Singh, Harshabad
    Keller, Rachel B.
    Kapner, Kevin S.
    Dilly, Julien
    Raghavan, Srivatsan
    Yuan, Chen
    Cohen, Elizabeth F.
    Tolstorukov, Michael
    Andrews, Elizabeth
    Brais, Lauren K.
    da Silva, Annacarolina
    Perez, Kimberly
    Rubinson, Douglas A.
    Surana, Rishi
    Giannakis, Marios
    Ng, Kimmie
    Clancy, Thomas E.
    Yurgelun, Matthew B.
    Schlechter, Benjamin L.
    Clark, Jeffrey W.
    Shapiro, Geoffrey I.
    Rosenthal, Michael H.
    Hornick, Jason L.
    Nardi, Valentina
    Li, Yvonne Y.
    Gupta, Hersh
    Cherniack, Andrew D.
    Meyerson, Matthew
    Cleary, James M.
    Nowak, Jonathan A.
    Wolpin, Brian M.
    Aguirre, Andrew J.
    CLINICAL CANCER RESEARCH, 2023, 29 (22) : 4627 - 4643
  • [5] KRAS wild-type pancreatic ductal adenocarcinoma: Molecular and therapeutic opportunities.
    Desai, Aakash
    Walden, Daniel
    Halfdanarson, Thorvardur Ragnar
    Alberts, Steven R.
    McWilliams, Robert R.
    Mahipal, Amit
    Ahn, Daniel H.
    Babiker, Hani M.
    Tella, Sri Harsha
    McGarrah, Patrick Walsh
    Kizilbash, Sani Haider
    Adjei, Alex A.
    Bekaii Saab, Tanios S.
    Ma, Wen Wee
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
    Luchini, Claudio
    Paolino, Gaetano
    Mattiolo, Paola
    Piredda, Maria L.
    Cavaliere, Alessandro
    Gaule, Marina
    Melisi, Davide
    Salvia, Roberto
    Malleo, Giuseppe
    Shin, Jae Il
    Cargnin, Sarah
    Terrazzino, Salvatore
    Lawlor, Rita T.
    Milella, Michele
    Scarpa, Aldo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [7] KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
    Claudio Luchini
    Gaetano Paolino
    Paola Mattiolo
    Maria L. Piredda
    Alessandro Cavaliere
    Marina Gaule
    Davide Melisi
    Roberto Salvia
    Giuseppe Malleo
    Jae Il Shin
    Sarah Cargnin
    Salvatore Terrazzino
    Rita T. Lawlor
    Michele Milella
    Aldo Scarpa
    Journal of Experimental & Clinical Cancer Research, 39
  • [8] Clinical and molecular features of patients with KRAS wild-type pancreatic adenocarcinoma
    Ben-Ammar, I.
    Tarabay, A.
    Hollebecque, A.
    Tanguy, M.
    Boige, V.
    Malka, D.
    Smolenschi, C.
    Ducreux, M.
    Boileve, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S356 - S356
  • [9] Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
    Philip, Philip A.
    Azar, Ibrahim
    Xiu, Joanne
    Hall, Michael J.
    Hendifar, Andrew Eugene
    Lou, Emil
    Hwang, Jimmy J.
    Gong, Jun
    Feldman, Rebecca
    Ellis, Michelle
    Stafford, Phil
    Spetzler, David
    Khushman, Moh'd M.
    Sohal, Davendra
    Lockhart, A. Craig
    Weinberg, Benjamin A.
    El-Deiry, Wafi k S.
    Marshall, John
    Shields, Anthony F.
    Korn, W. Michael
    CLINICAL CANCER RESEARCH, 2022, 28 (12) : 2704 - 2714
  • [10] Wild-type KRAS dosage in mutant KRAS lung cancer: Implications for tumorigenesis and therapeutic response
    Ivanisevic, Tonci
    Vande Velde, Greetje
    Zhao, Peihua
    Magits, Wout
    Sewduth, Raj N.
    Sablina, Anna A.
    CANCER RESEARCH, 2024, 84 (06)
12345